Doctor profile · Federal record
Dr. Gisela Velez, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Retina Specialist (Ophthalmology) Physician · Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician · Ayer, MA
- NPI 1639119167
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 32 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
190 Groton RD, Suite 240
Ayer, MA 014321124
(978) 772-4000
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- April 26, 2019
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (2)
- Massachusetts #210293 · Massachusetts #21093
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639119167. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
17,321
Distinct HCPCS
10
Medicare allowed
$3,115,483
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
92134 |
Imaging of retina | 3,570 | 879 | $44 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 2,497 | 725 | $140 | |
Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1,785 | 50 | $215 | |
J0178 |
Injection, aflibercept, 1 mg | 1,464 | 75 | $867 | |
67028 |
Injection of drug into eye | 1,373 | 152 | $125 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 1,252 | 710 | $17 | |
92083 |
Exam of visual field with extended testing | 1,162 | 644 | $69 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 743 | 50 | $225 | |
92273 |
Measurement of retinal and optic nerve function | 653 | 423 | $138 | |
92250 |
Photography of the retina | 647 | 463 | $41 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 824. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$1,258
Transactions
50
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $497.36 | |
| Tarsus Pharmaceuticals, Inc. | 4 | $151.91 | |
| Thea Pharma Inc. | 5 | $123.35 | |
| Alcon Vision LLC | 5 | $112.59 | |
| Sandoz Inc. | 2 | $86.32 | |
| Coherus Biosciences Inc. | 2 | $77.20 | |
| Astellas Pharma US Inc | 3 | $71.90 | |
| Oyster Point Pharma, Inc. | 1 | $29.96 | |
| Bausch & Lomb Americas Inc. | 1 | $24.98 | |
| Alimera Sciences, Inc. | 1 | $23.51 | |
| Biogen, Inc. | 1 | $21.56 | |
| Apellis Pharmaceuticals, Inc. | 1 | $20.40 | |
| Sight Sciences, Inc. | 1 | $17.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,152
Patients
984
Total drug cost
$394,739
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 1,090 | 327 | $27,752 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 500 | 148 | $17,453 |
| Brimonidine Tartrate | Generic | 207 | 66 | $9,419 |
| Timolol Maleate | Generic | 182 | 55 | $6,610 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 175 | 96 | $3,557 |
| Rhopressa (Netarsudil Mesylate) | Brand | 142 | 36 | $91,816 |
| Prednisolone Acetate | Generic | 140 | 52 | $10,815 |
| Ketorolac Tromethamine | Generic | 136 | 41 | $4,167 |
| Dorzolamide Hcl | Generic | 135 | 32 | $3,614 |
| Rocklatan (Netarsudil Mesylat/Latanoprost) | Brand | 116 | 40 | $81,100 |
Frequently asked questions
What is Dr. Gisela Velez's medical specialty?
Dr. Gisela Velez practices Ophthalmology Physician in Ayer, MA.
Where does Dr. Gisela Velez practice?
Dr. Gisela Velez practices at 190 Groton RD, Ayer, MA 014321124. Office phone: 9787724000.
What is Dr. Gisela Velez's NPI?
Dr. Gisela Velez's National Provider Identifier (NPI) is 1639119167, issued by NPPES.
Does Dr. Gisela Velez accept Medicare assignment?
Yes. Dr. Gisela Velez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gisela Velez commonly perform?
Top Medicare-reported procedures in 2023: Imaging of retina (HCPCS 92134); Established patient office or other outpatient visit (HCPCS 99214); Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg (HCPCS Q5124). Source: CMS Medicare Physician & Other Practitioners file.